Project Launched by VTT Develops Computer Models for Predicting Dietary Effects on Health

VTT is launching an extensive EU project called ETHERPATHS, studying the effects of dietary effects mediated by gut microbiota on lipid metabolism. The aim is to accelerate the development of health-promoting foods. The project develops computer assisted models with which food companies and research institutions, for instance, will be able to predict the effects of foods in the body.

The ETHERPATHS project focuses on the balance of lipid metabolism in the body, the effects of foods in tissues and the role of gut microbiota in these processes. Lipid metabolism disorders are associated with several common health care problems, such as ageing, diabetes and cardiovascular diseases. The balance can be influenced by dietary means. The risk of chronic diseases decreases with a diet containing particularly omega-3 fatty acids and foods that contain fibres and phenol. Therefore, fatty fish, berries, fruits and vegetables may be favourable foods in terms of lipid metabolism balance. The body’s own phospholipids are assumed to mediate the health-promoting effects, but their mechanisms of action are still unknown.

The project develops computer-assisted models that emulate the changes in lipid metabolism brought about by eating fish and vegetable oil, berries, fruits and vegetables. The use of models makes it easier to combine data from animal studies and cell-level data in the interpretation of research data from clinical trials, thus promoting research in the health effects of foods and development of foodstuffs. The results of the project and the tools developed in it will in time also be available to in addition to food companies to companies and research institutions that develop diagnostics of health and disease.

The coordinator of the ETHERPATHS project is VTT's Research Professor Matej Oresic. The total project budget for 2009–2012 is EUR 8 million, of which VTT's share is EUR 2.5 million. The project involves a total of 10 European research institutions and companies.

The project partners are: VTT (Finland), University of Barcelona (Spain), University of Gothenburg (Sweden), University of Cambridge (United Kingdom), Institute for Systems Biology SPb (Russia), Federico II University of Naples (Italy), Noray Bioinformatics S.L.U. (Spain), BioMotif AB (Sweden), Advion Biosciences, Ltd. (United Kingdom) and Nestle Research Center (Switzerland). The project is part of the EU FP7 Cooperation Work Programme: Food, agriculture and fisheries, and biotechnology programme (KBBE-2007-2-2-08).

About VTT Technical Research Centre of Finland
VTT Technical Research Centre of Finland is the biggest contract research organization in Northern Europe. VTT provides high-end technology solutions and innovation services. From its wide knowledge base, VTT can combine different technologies, create new innovations and a substantial range of world-class technologies and applied research services, thus improving its clients' competitiveness and competence. Through its international scientific and technology network, VTT can produce information, upgrade technology knowledge and create business intelligence and value added to its stakeholders. For more information, visit http://www.vtt.fi.

Most Popular Now

Philips Foundation 2024 Annual Report: E…

Marking its tenth anniversary, Philips Foundation released its 2024 Annual Report, highlighting a year in which the Philips Foundation helped provide access to quality healthcare for 46.5 million people around...

New AI Transforms Radiology with Speed, …

A first-of-its-kind generative AI system, developed in-house at Northwestern Medicine, is revolutionizing radiology - boosting productivity, identifying life-threatening conditions in milliseconds and offering a breakthrough solution to the global radiologist...

Scientists Argue for More FDA Oversight …

An agile, transparent, and ethics-driven oversight system is needed for the U.S. Food and Drug Administration (FDA) to balance innovation with patient safety when it comes to artificial intelligence-driven medical...

New Research Finds Specific Learning Str…

If data used to train artificial intelligence models for medical applications, such as hospitals across the Greater Toronto Area, differs from the real-world data, it could lead to patient harm...

Giving Doctors an AI-Powered Head Start …

Detection of melanoma and a range of other skin diseases will be faster and more accurate with a new artificial intelligence (AI) powered tool that analyses multiple imaging types simultaneously...

AI Agents for Oncology

Clinical decision-making in oncology is challenging and requires the analysis of various data types - from medical imaging and genetic information to patient records and treatment guidelines. To effectively support...

Patients say "Yes..ish" to the…

As artificial intelligence (AI) continues to be integrated in healthcare, a new multinational study involving Aarhus University sheds light on how dental patients really feel about its growing role in...

Brains vs. Bytes: Study Compares Diagnos…

A University of Maine study compared how well artificial intelligence (AI) models and human clinicians handled complex or sensitive medical cases. The study published in the Journal of Health Organization...

'AI Scientist' Suggests Combin…

An 'AI scientist', working in collaboration with human scientists, has found that combinations of cheap and safe drugs - used to treat conditions such as high cholesterol and alcohol dependence...

Start-ups in the Spotlight at MEDICA 202…

17 - 20 November 2025, Düsseldorf, Germany. MEDICA, the leading international trade fair and platform for healthcare innovations, will once again confirm its position as the world's number one hotspot for...